PatternsRadar
Sign in

MANKINDMankind Pharma Limited

NSEF&O
2,665.00INR+36.00 (+1.37%)Close · 20 Nov 2026
26 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1.10L CrMarket cap
49.0P/E (TTM)
53.8%Delivery

Filings & corporate actions

15 results filed
CSV
Next results · Q3 FY27
Expected 24 Jan 2027 – 3 Feb 2027
Estimate: filed 24–34 days after quarter end, last 3 times
Dividend
₹1.00 per share · last 8 Aug 2025
2026
  • 26 OctresultsResults · Q2 FY27 · consolidated and standalone+8.2%NSE
  • 16 OctshareholdingShareholding · 30 Sept 2026-3.1%NSE
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone-4.1%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+0.5%NSE
  • 19 MayresultsResults · Q4 FY26 · consolidated and standalone+3.7%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.9%NSE
  • 3 FebresultsResults · Q3 FY26 · consolidated and standalone-3.4%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-0.5%NSE

Reaction to results · all yearsrose on day 0 in 7 of 15 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2726 Oct 2026+8.2%+7.1%—4.7×
Q1 FY2730 Jul 2026-4.1%-4.7%-7.5%6.5×
Q4 FY2619 May 2026+3.7%-2.9%-3.5%7.5×
Q3 FY263 Feb 2026-3.4%-3.5%+3.0%2.3×
Q2 FY266 Nov 2025-2.0%-1.8%-4.5%3.0×
Q1 FY2631 Jul 20250.0%-3.9%-0.9%0.7×
Q4 FY2521 May 2025-3.6%-2.7%-8.1%2.9×
Q3 FY2524 Jan 2025-4.9%-7.6%-10.9%3.0×
Q2 FY255 Nov 2024+1.3%-6.7%-4.7%6.6×
Q1 FY2531 Jul 2024-1.2%+2.2%+22.7%2.7×
Q4 FY2415 May 2024-4.5%-4.1%+2.3%8.4×
Q3 FY2431 Jan 2024+2.3%+12.5%+6.8%3.1×
Q2 FY2431 Oct 2023+0.1%+5.9%+9.0%2.3×
Q1 FY242 Aug 2023+9.1%+5.9%-1.3%5.9×
Q4 FY2331 May 2023+2.6%+7.1%+25.5%—
Average+0.2%+0.2%+2.0%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+17.3%
Profit YoY+39.1%
Interest cost YoY-31.6%
Revenue QoQ+7.6%
Profit QoQ+23.9%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+18.1%—————
Profit+3.1%—————

Key data

Open2,627.00
Day range2,620.20 – 2,669.90
52-week range1,909.70 – 2,705.00
From 52w high-1.5%
RSI (14)66.1
ATR (14)63.20
Volume4.56L
Avg volume (20D)7.13L
Rel volume0.64×
Volatility (1Y)28.5%
Turnover₹120.6Cr
Traded value (NSE)₹120.6Cr
VWAP2,646.07
SMA 50 / 2002,448.73 / 2,345.58
Price bandNo band
MWPL used17.4%

Delivery percentage

Latest · 20 Nov 202653.8%
20-day avg49.3%
1-year avg54.8%
Percentile (own history)38th
Range7.5–93.9%
Sessions880

Over the last 20 sessions MANKIND settled 49.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 54.8%, so recent sessions are running 5.5 points lower than usual. The latest session ranks higher than 38% of the 880 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders1.64L · -1.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever

Performance returns

1D1W1M3M6M1Y
Price+1.37%+0.95%+17.11%+11.74%+6.00%+17.55%

Valuation

Market cap₹1.10L Cr
Market cap (NSE)₹1.10L Cr
Free-float cap₹30,139 Cr
P/E (TTM)49.0
P/E (NSE)48.0
EPS (TTM)54.44
P/B6.3
Net margin (TTM)14.6%
Other income / PBT11.5%
ROE13.7%
Debt / equity0.30
Shares outstanding41.30Cr
Listed9 May 2023

Ownership

Promoter72.62%
Promoter Δ QoQ-0.01 pp
Public27.38%
FII9.37%
DII15.56%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)3,567.23,442.94,030.64,337.9
YoY chg+10.4%+11.8%+12.9%+17.3%
Net profit (₹ Cr)413.9559.4574.1716.1
YoY chg+7.6%+31.7%+29.1%+37.7%
Net margin11.6%16.2%14.2%16.5%
EPS9.8913.4113.7417.20

Shareholding over time

By quarter

30 Sept 2026 · promoter 72.62% · public 27.38%
4 May 2023: promoter 76.50%30 Jun 2023: promoter 76.50%30 Sept 2023: promoter 76.50%31 Dec 2023: promoter 76.50%31 Mar 2024: promoter 74.88%30 Jun 2024: promoter 74.87%30 Sept 2024: promoter 74.87%20 Dec 2024: promoter 72.71%31 Dec 2024: promoter 72.71%31 Mar 2025: promoter 72.70%30 Jun 2025: promoter 72.68%30 Sept 2025: promoter 72.67%31 Dec 2025: promoter 72.66%31 Mar 2026: promoter 72.66%30 Jun 2026: promoter 72.63%30 Sept 2026: promoter 72.62%
2023-052026-09
  • Promoter
  • Public and others
Promoter
72.62%
Public
27.38%
Promoter change
-0.01 pp
Filed
16 Oct 2026
FII
9.37%
DII
15.56%
Promoter pledged
0.00%

Who the public is

Mutual funds
11.31%

+0.44 pp QoQ

Insurance
1.37%

-0.17 pp QoQ

FPI
9.37%

-0.08 pp QoQ

Retail ≤ ₹2L
1.26%

-0.03 pp QoQ

HNI > ₹2L
0.00%

0.00 pp QoQ

NRI
0.06%

+0.01 pp QoQ

Bodies corporate
1.04%

0.00 pp QoQ

Shareholders
1,63,770

-1.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee)Promoter · Other20.18%
Rajeev Juneja Family Trust (Held in the name of Rajeev Juneja, Managing Trustee)Promoter · Other19.35%
Prem Sheetal Family Trust (Held in the name of Arora Family Private Limited, Trustee)Promoter · Other14.95%
SHEETAL ARORAPromoter · Individual4.67%
PUJA JUNEJAPromoter · Individual2.79%
NPS TRUST- A/C LIC PENSION FUND SCHEME - STATE GOVPension / PF2.65%
POONAM JUNEJAPromoter · Individual2.56%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA RETMutual fund2.45%
ARJUN JUNEJAPromoter · Individual1.97%
RAMESH JUNEJAPromoter · Individual1.66%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 8 Aug 2025 CSV
Financial yearPaymentsDeclaredAdjusted
FY2025-261₹1.00₹1.00
Ex-dateRecord dateDeclaredAdjusted
8 Aug 2025—₹1.00₹1.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
3
3 open-market of the newest 3
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
9 Feb 2024Puja JunejaPromoterSell22.71L₹478.6Cr2,107.351.38Cr → 1.15Cr2.88%-0.57 pp7(2)told 9 Feb 2024
9 Feb 2024Arjun JunejaPromoterSell24.01L₹506.0Cr2,107.351.06Cr → 81.54L2.04%-0.60 pp7(2)told 9 Feb 2024
9 Feb 2024Sheetal AroraPromoterSell18.17L₹382.9Cr2,107.352.11Cr → 1.93Cr4.81%-0.45 pp7(2)told 9 Feb 2024

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 14 Oct 2025

CSV
12 of 93 deals
By year
DateDealClientQuantityPriceValue
14 Oct 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE - ODI55.0K2,430.00₹13.4Cr
14 Oct 2025Buy · blockGOLDMAN SACHS BANK EUROPE SE - ODI55.0K2,430.00₹13.4Cr
13 Oct 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE - ODI42.2K2,440.00₹10.3Cr
13 Oct 2025Buy · blockGOLDMAN SACHS BANK EUROPE SE - ODI42.2K2,440.00₹10.3Cr
5 Feb 2025Sell · blockCOPTHALL MAURITIUS INVESTMENT LIMITED45.0K2,555.10₹11.5Cr
5 Feb 2025Buy · blockORBIMED GENESIS MASTER FUND L.P.45.0K2,555.10₹11.5Cr
10 Jul 2024Sell · blockHEMA CIPEF (I) LIMITED18.51L2,082.00₹385.3Cr
10 Jul 2024Buy · blockICICI PRUDENTIAL MUTUAL FUND A/C ICICI PRUDENTIAL INDIA OPPORTUNITIES FUND4.37L2,082.00₹91.0Cr
10 Jul 2024Buy · blockICICI PRUDENTIAL MUTUAL FUND3.62L2,082.00₹75.4Cr
10 Jul 2024Buy · blockMORGAN STANLEY ASIA SINGAPORE PTE3.37L2,082.00₹70.1Cr
10 Jul 2024Buy · blockPICTET - INDIAN EQUITIES3.21L2,082.00₹66.9Cr
10 Jul 2024Buy · blockNORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL2.89L2,082.00₹60.1Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to MANKIND.

Price band: No band · not in the F&O ban · 17.4% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes · MWPL.

Every stock on this session →

Futures & options · 20 Nov 2026

CSV

Short covering — price up as positions closed — shorts buying back.

Futures OI
29.56L

₹787.8Cr

OI change
-2.94%
Basis
-0.47%
Rollover
74.9%
PCR (OI)
0.72
PCR (volume)
0.40
Front settle
2,652.40
Lot size
250

shares

Futures volume
5.8K

contracts

Futures trades
5,237
Futures value
₹386.7Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Option chain · 20 Nov 2026 · lot 250

Put OICall OI
Max pain
2,540

-4.7% from spot

Call OI wall
2,700
Put OI wall
2,300
PCR (OI, this expiry)
0.75
PutsStrikeCalls
2,300PW
2,320
2,340
2,360
2,380
2,400
2,420
2,440
2,460
2,480
2,500
2,520
2,540MP
2,560
2,580
2,600
2,620
2,640
2,660
Spot 2,664.84
2,680
2,700CW
2,720
2,740
2,760
2,780
2,800
2,820
2,840
2,860
2,880
2,920

2,540: puts 28.0K OI (−24.8K), close 1.90, ₹17.0Cr notional in 199 trades · calls 53.5K OI (−6.0K), close 109.40, ₹4.4Cr notional in 66 trades

Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations2,607.02,441.12,893.43,076.53,230.03,079.43,570.43,697.23,567.23,442.94,030.64,337.9
Other income70.192.1100.6109.477.3251.379.991.972.8114.345.094.9
Total income2,677.12,533.22,994.03,185.93,307.33,330.73,650.23,789.03,640.03,557.24,075.64,432.7
Total expenses2,119.41,964.12,330.32,339.22,813.42,817.63,112.93,167.33,027.62,877.93,310.13,507.3
└ Finance costs9.29.410.97.1220.9190.5170.7169.7157.2141.8110.0104.9
└ Depreciation109.7104.7107.7105.6192.3230.9218.7221.8222.6223.1225.7235.7
Profit before tax557.7569.2663.7846.8493.9513.1537.3621.7505.8656.2765.5925.4
Tax expense102.595.0124.6190.4112.886.495.9103.895.199.8195.4213.0
Net profit459.8476.6543.1658.9384.5424.7444.6520.2413.9559.4574.1716.1
EPS11.3311.7613.3916.319.4510.1910.6212.399.9013.4413.7617.23
Net margin17.64%19.52%18.77%21.42%11.90%13.79%12.45%14.07%11.60%16.25%14.24%16.51%
PBT margin21.39%23.32%22.94%27.52%15.29%16.66%15.05%16.82%14.18%19.06%18.99%21.33%
Tax rate18.38%16.69%18.77%22.49%22.84%16.85%17.84%16.70%18.81%15.20%25.52%23.02%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 26 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets9,715.411,098.311,963.313,982.327,759.528,813.328,079.528,954.4
Current assets4,427.15,738.76,647.58,611.37,175.18,288.37,139.78,068.9
└ Cash & equivalents304.8253.5382.0726.6407.4327.8391.71,113.8
└ Other bank balances148.4329.1816.0466.0147.1231.591.123.3
└ Current investments1,075.51,743.32,258.13,534.21,690.82,545.41,537.31,432.8
└ Trade receivables576.41,057.2848.31,271.91,538.31,900.61,729.52,179.3
└ Inventories1,498.51,533.81,553.51,678.92,093.71,971.82,144.52,345.1
Total equity7,623.38,633.69,575.810,789.314,568.215,528.716,561.117,855.2
└ Attributable to owners7,435.28,428.49,363.110,564.814,332.415,286.016,300.317,582.2
└ Non-controlling interest188.1205.1212.7224.5235.8242.7260.7273.0
└ Share capital40.140.140.140.141.341.341.341.3
Borrowings170.4179.4207.2482.18,511.58,368.76,311.55,421.7
└ Current142.0150.6174.6455.02,971.24,160.33,418.92,320.4
└ Non-current28.328.832.627.15,540.24,208.32,892.73,101.3
Trade payables1,008.21,112.61,103.01,518.61,133.41,301.41,341.31,631.0
Current liabilities1,863.12,128.42,119.72,893.55,663.67,097.66,507.35,884.8
Total liabilities2,092.22,464.72,387.53,193.013,191.413,284.611,518.511,099.1
Net debt(1,358.3)(2,146.5)(3,248.9)(4,244.7)6,266.15,264.04,291.52,851.8
Debt / equity0.020.020.020.040.580.540.380.30
Current ratio2.382.703.142.981.271.171.101.37

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow1,813.3968.92,152.41,139.32,413.41,636.73,121.31,818.5
└ Capex(832.1)(224.6)(382.3)(253.2)(520.1)(290.3)(737.2)(412.0)
Free cash flow981.2744.31,770.1886.21,893.31,346.42,384.11,406.5
Investing cash flow(1,054.1)(1,015.0)(2,081.7)(1,035.4)(12,683.0)(1,168.2)(196.4)22.4
Financing cash flow(739.7)(6.8)5.3240.510,290.1(549.3)(2,952.7)(1,118.8)
└ Dividends paid0.00.00.00.00.0(41.3)(41.3)0.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash19.4(51.3)77.2344.620.6(80.8)(27.8)722.1

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

MANKIND at a glance

  • MANKIND closed at ₹2,665 on 20 Nov 2026, +1.37% on the day, +17.6% over one year, 1.5% below its 52-week high of ₹2,705.
  • Delivery was 53.8% of traded quantity on 20 Nov 2026, the 38th percentile of its own 880 sessions with a reading (20-session average 49.3%, 1-year average 54.8%).
  • Market capitalisation is ₹1.10 lakh crore at a trailing P/E of 49.0 (trailing EPS ₹54.44).
  • Q2 FY27 results (consolidated, filed 26 Oct 2026): revenue ₹4,338 crore (+17.3% year on year), net profit ₹716 crore (+37.7%); the price moved +8.2% on the first session after.
  • Promoters held 72.62% at 30 Sept 2026, down 0.01 percentage points on the previous filing.
  • Q3 FY27 results are expected between 24 Jan 2027 and 3 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE634S01028
SeriesEQ
Listed9 May 2023
IPO price1,080.00 · band Rs.1026 to Rs.1080
IPO listing9 May 2023
NSE market cap · 17 Nov 2026₹1.08L Cr
Free-float market cap (NSE)₹29,499 Cr
Shares outstanding (NSE)41.30Cr
History from9 May 2023
Sessions880
Turnover rank#162

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.